[January 09, 2013]

Research and Markets: The Global Microfluidic Devices Market in the Healthcare Industry to Grow At A CAGR Of 26.7 Percent over the Period 2011-2015

Research and Markets (http://www.researchandmarkets.com/research/fnv97g/global) has announced the addition of the "Global Microfluidic Devices Market in the Healthcare 2011-2015" report to their offering.

One of the key factors contributing to this market growth is the increasing use of microfluidic devices in proteomics and genomics. The Global Microfluidic Devices market in the Healthcare industry has also been witnessing the trend of the increasing use of microfluidic devices in drug discovery. However, the intense competition among vendors could pose a challenge to the growth of this market.

The key vendors dominating this market space are Fluidigm Corp., RainDance Technologies Inc., Agilent (News - Alert) Technoloies Inc., and Dolomite Centre Ltd.

The other vendors mentioned in the report are Micronit Microfluidics BV, Illumina Inc., MicruX Technologies Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, BioFluidix GmbH, Abaxis Inc., Advion Biosciences Inc., Caliper Life Sciences Inc., Cepheid Inc., Danaher (News - Alert) Corp., Eksigent Technologies Inc., GE Novasensor Inc., Illumina Inc., Johnson and Johnson, Konica Minolta Holdings Inc., Microfluidic Systems Inc., Life Technologies Corp., Philips (News - Alert) Healthcare, Roche Diagnostics, Shimadzu Biotech, and Siemens Healthcare.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The market is witnessing the increasing use of microfluidic devices in drug discovery. Microfluidic devices are used in drug discovery because they significantly reduce the time and cost of producing drugs. They help in producing large amounts of biological materials such as proteins or enzymes required for drug screening. This helps drug development companies to reduce the initial expenses of drug development and at the same time gain speed in bringing a drug to market.''

According to the report, the market is witnessing the increasing use of microfluidic devices in Point of Care (POC) testing. Microfluidic devices are used in POC testing because they aid in the diagnosis of diseases in the presence of patients, which ensures convenience. The glucose monitor, one of the first microfluidic-based POC diagnostic devices, has become a standard commodity because it is inexpensive to make and works well.

For more information visit http://www.researchandmarkets.com/research/fnv97g/global

[ Back To Technology News's Homepage ]